SCHEMBL20123030

SCHEMBL20123030

CCc1cc2c([nH]c3c(-c4ccc(OC)cc4)cc(Br)cc32)c(C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.39
DYRK1B Q9Y463 1/20 0.36
ACHE P22303 2/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
RAB9A P51151 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MAOB P27338 1/20 0.34
CRHR1 P34998 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 2/20 0.34
ADCY1 Q08828 1/20 0.34
NPC1 O15118 2/20 0.33
GAA P10253 2/20 0.33
ACACA Q13085 1/20 0.33
TGFBR1 P36897 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30664205 1.00 DYRK1A (0.49) DYRK1AL3MBTL1DYRK1BACHEMEN1
SCHEMBL20122824 0.86 DYRK1A (0.55) DYRK1ADYRK1BACHEMEN1KMT2A
SCHEMBL30664158 0.86 DYRK1A (0.55) DYRK1ADYRK1BACHEMEN1KMT2A
SCHEMBL20122918 0.80 MAOA (0.54) DYRK1ADYRK1BACHEKDM4EALDH1A1
SCHEMBL29756413 0.80 MAOA (0.54) DYRK1ADYRK1BACHEKDM4EALDH1A1
SCHEMBL22474563 0.80 PRKAB2 (0.42) DYRK1AKMT2AALDH1A1GAA
SCHEMBL30664132 0.80 PRKAB2 (0.42) DYRK1AKMT2AALDH1A1GAA
SCHEMBL20122962 0.68 MAOA (0.56) DYRK1ADYRK1BACHEMEN1KMT2A
SCHEMBL21384140 0.66 DYRK1A (1.00) DYRK1ADYRK1BACHEMEN1KMT2A
SCHEMBL20123029 0.66 MAPT (0.53) DYRK1AMEN1KMT2ARAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2021-09-28 US disclosed
EP-3792262-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2021-03-17 EP disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed
EP-3318563-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2018-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 DYRK1A 493/4885L3MBTL1 3291/4885DYRK1B 232/4885
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 DYRK1A 493/4885L3MBTL1 3291/4885DYRK1B 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.